General
Preferred name
PYRVINIUM PAMOATE
Synonyms
Pyrvinium embonate ()
PYRVINIUM ()
Poquil ()
Viprynium Embonate ()
Vanquil ()
Pyrvinium (as embonate) ()
Vanquin ()
NSC-223622 ()
Povan ()
Pyrvinium (pamoate) ()
P&D ID
PD051663
CAS
3546-41-6
Tags
available
drug
Drug Status
approved
Max Phase
Phase 4
Drug indication
Anthelmintic
First approval
1982
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
2
Compound Sets
9
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Enamine BioReference Compounds
MedChem Express Bioactive Compound Library
Prestwick Chemical Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
19
Properties
(calculated by RDKit )
Molecular Weight
1150.54
Hydrogen Bond Acceptors
10
Hydrogen Bond Donors
2
Rotatable Bonds
12
Ring Count
12
Aromatic Ring Count
12
cLogP
12.34
TPSA
144.82
Fraction CSP3
0.15
Chiral centers
0.0
Largest ring
6.0
QED
0.12
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
Cytoskeletal Signaling
Stem Cells
Stem Cell/Wnt
Target
Wnt
Parasite
Source data
